hypothesis glutathione persister cells Low-GPX4 drives a sustained drug-tolerant state in TNBC by a targetable adaptive FSP1 upregulation Dosage:10/10mg (best value) restore pigmentation NAD+ IV Push -
SKU: 45127193471
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28

















